Document:

EX-10.8

 Exhibit 10.8 

Good Works II Acquisition Corp. 

4265 San Felipe, Suite 603 

Houston, TX 77027 

            , 2021 

Shoreline Capital Advisors, Inc. 
 1536 Whispering
Pines Drive 
 Houston, TX 77055 

Re: Administrative Services Agreement 

Ladies and Gentlemen: 
 This letter agreement by
and between Good Works II Acquisition Corp. (the “Company”) and Shoreline Capital Advisors (the “Consultant”), dated as of the date hereof, will confirm our agreement that, commencing on the date the securities of the Company are
first listed on The Nasdaq Capital Market (the “Listing Date”), pursuant to a Registration Statement on Form S-1 and prospectus filed with the U.S. Securities and Exchange Commission (the
“Registration Statement”) and continuing until the earlier of (i) the consummation by the Company of an initial business combination, (ii) the Company’s liquidation, or (iii) 15 months after the Listing Date (in each case as
described in the Registration Statement) (such earlier date hereinafter referred to as the “Termination Date”): 
 (i) The
Consultant shall make available, or cause to be made available, to the Company, at 4265 San Felipe, Suite 603, Houston, TX 77027 (or any successor location of Consultant), certain office space, utilities and secretarial and administrative
services as may be reasonably required by the Company. In exchange therefor, the Company shall pay to the Consultant the sum of $10,000 per month on the Listing Date and continuing monthly thereafter until the Termination Date; and 

(ii) The Consultant hereby irrevocably waives any and all right, title, interest, causes of action and claims of any kind as a result of, or
arising out of, this letter agreement (each, a “Claim”) in or to, and any and all right to seek payment of any amounts due to it out of, the trust account established for the benefit of the public stockholders of the Company and into which
substantially all of the proceeds of the Company’s initial public offering will be deposited (the “Trust Account”) as a result of, or arising out of, this letter agreement, and hereby irrevocably waives any Claim it may have in the
future, which Claim would reduce, encumber or otherwise adversely affect the Trust Account or any monies or other assets in the Trust Account, and further agrees not to seek recourse, reimbursement, payment or satisfaction of any Claim against the
Trust Account or any monies or other assets in the Trust Account for any reason whatsoever. 
 This letter agreement constitutes the entire
agreement and understanding of the parties hereto in respect of its subject matter and supersedes all prior understandings, agreements, or representations by or among the parties hereto, written or oral, to the extent they relate in any way to the
subject matter hereof or the transactions contemplated hereby. 
 This letter agreement may not be amended, modified or waived as to any
particular provision, except by a written instrument executed by the parties hereto. 
 No party hereto may assign either this letter
agreement or any of its rights, interests, or obligations hereunder without the prior written approval of the other party. Any purported assignment in violation of this paragraph shall be void and ineffectual and shall not operate to transfer or
assign any interest or title to the purported assignee. 
 This letter agreement constitutes the entire relationship of the parties hereto,
and any litigation between the parties (whether grounded in contract, tort, statute, law or equity) shall be governed by, construed in accordance with, and interpreted pursuant to the laws of the State of Delaware, without giving effect to its
choice of law principles. 

 
					
	Very truly yours,
	
	GOOD WORKS II ACQUISITION CORP.
		
	By:	 	  

		 	Name:	 	Fred Zeidman
		 	Title:	 	Chief Executive Officer

  

					
	AGREED TO AND ACCEPTED BY:
	
	SHORELINE CAPITAL ADVISORS
		
	By:	 	  

		 	Name:	 	Cary Grossman
		 	Title:	 	President

 [Signature Page to Administrative Services Agreement]EX-10.1

 Exhibit 10.1 
  

 
 May 28, 2021 
 James
Corbett 
 17 Bravo Lane 
 Aliso Viejo, CA 92656 

 

	Re:	 Appointment to Board of Directors 

Dear Jim: 
 I am pleased to confirm our offer
regarding your appointment as a member of the Board of Directors of AVITA Medical Inc., a Delaware corporation (the “Company”), which will commence with effect on July 1, 2021 (the “Effective Date”), on
the following terms: 
  

	1.	 Position. 

Your position as a Director of the Company will require formal acceptance of this appointment, by executing this letter agreement as of a date
no later than July 1, 2021. Your term as a Director will commence on the Effective Date and you will be subject to annual re-election by the shareholders at the Company’s annual shareholder meeting
which takes place on or around October/November of each year. 
  

	2.	 Duties. 

(a) As a non-executive director your duties involve commitment of your time to board meetings. We
currently have four scheduled meetings per year which is subject to re-examination next year in which the frequency of the meetings may increase, plus additional board meetings, including strategy meetings.
Additionally, there are committee meetings to which you may be appointed and we currently have four scheduled meetings per year per committee which is subject to re-examination next year in which the frequency
of the meetings may increase. Whilst there is a clear need for in-person meetings, during unforeseen events, such as the current pandemic, your attendance may be requested via teleconferencing. 

(b) The Company understands and agrees that during your term as a Director you may serve in other capacities for the Company, including as an
executive, consultant or advisor, and that you may also serve in like capacities for other companies not affiliated with the Company that are not Company competitors, subject to your obligations contained in this letter agreement. Any potential new
appointments should be discussed with the Board Chair prior to acceptance, to allow consideration of matters including conflict of interest, and the time you can devote to your position as a non-executive
director of AVITA. 
 AVITA Medical 

28159 Avenue Stanford, Suite 220 Valencia, CA 91355 

P +1(661) 367-9170 | f +1 (661) 367-9180 | avitamedical.com 

 

 
  

	3.	 Compensation. 

In consideration for your services to the Company as a non-executive Director, your current base
compensation, which is subject to shareholder approval at the annual shareholder meeting, is US $70,000 annually with additional paid membership of one or more committees that will be discussed with you in due course. Cash remuneration for board
directors is reviewed periodically with reference to peer company compensation and is subject to shareholder approval. An equity component of your compensation will be subject to shareholder approval at the annual shareholder meeting scheduled at
the end of the 2021 calendar year. 
  

	4.	 Expenses. 

As a non-executive Director you are entitled to reimbursement for reasonable company- related
expenditures incurred by you, including your travel to and from Board meetings, after receipt by the Company from you of an itemized expense report, together with receipts or other reasonable proof of such expenses. Travel is usually coordinated
through the office of the CEO. 
  

	5.	 Representations and Warranties. 

(a) You represent and warrant that (i) your performance of your obligations under this letter agreement will not infringe any intellectual
property, publicity or privacy rights of any third party, (ii) neither your advisory relationship with the Company, nor the performance of your obligations hereunder, will conflict with or result in a breach of any third-party agreement by
which you are currently bound, and (iii) your performance of your obligations under this letter agreement will not contain any defamatory or libelous material or material that discloses private or personal matters concerning any party, without
that party’s consent. 
 (b) You further understand that your role as a Director will be that of an independent contractor and that you
will not be an agent, employee or representative of the Company. You further understand that you will have no authority to enter into contracts or create obligations on the Company’s behalf. You acknowledge that you will not be eligible for any
employee benefits and that the Company will not make any tax withholdings on your behalf. You agree that you are obligated to report as income all consideration that you receive in connection with this letter agreement, and you agree to pay any
applicable self-employment and other taxes thereon, if any. You further agree to indemnify the Company and hold it harmless to the extent of any obligation imposed on the Company (i) to pay withholding taxes or similar items or
(ii) resulting from your being determined not to be an independent contractor. All compensation paid to you shall be reported by the Company to the Internal Revenue Service and any applicable state tax authorities on a Form 1099 or other
applicable form. 
  

	6.	 Confidential Information. 

You agree that you will (i) hold in strictest confidence the Company’s proprietary information and trade secrets and all other
information made known to you in connection with your relationship with the Company as a Director that has or could have commercial value or other utility in the Company’s business or prospective business (collectively, the
“Confidential Information”), and (ii) not use the Confidential Information except in connection with your relationship with the Company as a Director. 

  
 AVITA Medical 

28159 Avenue Stanford, Suite 220 Valencia, CA 91355 

P +1(661) 367-9170 | f +1 (661) 367-9180 | avitamedical.com 

 

 
  

 The Confidential Information will not include information that you can establish is or was
(i) received by you without an obligation of confidentiality from an unrelated third party that is not under an obligation of confidentiality to the Company and that has a legal right to disclose it, (ii) generally known or available in
the industry or to the general public either (A) prior to the Company’s disclosure of such information to you or (B) after the Company’s disclosure of such information to you through no action or inaction by you, or
(iii) required to be disclosed by applicable law, by order of court or the rules, regulations or order of any governmental agency. 

You agree that you will not improperly use or disclose any proprietary information or trade secrets received by you from any third party in
connection with your relationship with the Company as a Director. You recognize that the Company has received and in the future will receive confidential and proprietary information from third parties and that the Company will have a duty to
maintain the confidentiality of such information and to use it only for certain limited purposes. You agree to hold all such confidential and proprietary information in the strictest confidence, and you further agree that you will neither disclose
it to any person, firm or corporation nor use it in a manner that is inconsistent with the Company’s obligations to such third parties. 

To the extent that your service to the Company results directly in the creation of any new Intellectual Property (as defined below), you agree
that, as between you and the Company, the Company shall own the rights to such new Intellectual Property if such Intellectual Property (i) is developed using the equipment, facilities, supplies or Confidential Information of the Company, or
(ii) results from or is suggested by work performed by you on behalf of the Company, but only if you are explicitly engaged in performing direct work for the Company. For the purposes of this section, “Intellectual
Property” means any original works of authorship, inventions, concepts, improvements or trade secrets, whether or not patentable or registrable under copyright or similar laws. At the Company’s expense, you agree to execute all
documents and take all actions necessary or reasonably requested by the Company to document, perfect or assign the Company’s rights to Intellectual Property. Further, if you fail or refuse to execute any such instruments, you hereby appoint the
Company as your attorney-in-fact (this appointment to be irrevocable and a power coupled with an interest) to act on your behalf and to execute such documents. 

Upon the Company’s request at and after such time as your term as a Director terminates, you agree to return, and will not keep in your
possession, recreate or deliver to any third party, any and all documents and/or electronic files containing Confidential Information. 
  

	7.	 Indemnification. 

The Company will agree to defend and indemnify you and hold you harmless against liability that you incur within the scope of your service as a
Director of the Company, pursuant to and in accordance with all of the terms and conditions contained in the Indemnification Agreement on the Company’s standard form to be separately provided to you, which is to be executed and delivered by you
and the Company upon execution and delivery of this letter agreement. 
  

	8.	 Publicity. 

You and the Company agree to cooperate with each other to create any and all appropriate public or promotional announcements or press releases
concerning our relationship. 

  
 AVITA Medical 

28159 Avenue Stanford, Suite 220 Valencia, CA 91355 

P +1(661) 367-9170 | f +1 (661) 367-9180 | avitamedical.com 

 

 
  

	9.	 Term and Termination. 

This letter agreement will commence on the Effective Date and will continue until such time as your term as a Director terminates. Upon such
termination all our rights and duties towards each other shall cease, except that this Section 9 and Sections 5, 6 and 10 shall survive termination of this letter agreement. 

 

	10.	 Other Provisions. 

Entire Agreement; Governing Law. This letter agreement constitutes the entire agreement between you and the Company and supersedes and
replaces any prior or contemporaneous agreements, representations or understandings, whether written, oral or implied, between you and the Company. This letter agreement will be interpreted, construed and enforced in all respects in accordance with
the laws of the State of Delaware, without regard to its conflict of laws rules. 
 Severability; Counterparts. If any provision of
this letter agreement is declared by any court of competent jurisdiction to be illegal, void or unenforceable, all other provisions will not be affected and will remain in full force and effect. This letter agreement may be executed in counterparts,
each of which is an original and which together constitute a single agreement. 
 Equitable Relief. You understand that monetary
damages will not adequately compensate the Company for a breach of your obligations. Accordingly, you agree that the Company may specifically enforce this letter agreement and that the Company will be entitled to seek a temporary or permanent
injunction or restraining order to prevent any breach or threatened breach of your obligations under this letter agreement. You thus hereby waive any claim or defense that there is an adequate remedy at law for such breach or threatened breach and
further agree that no bond or other security will be required in obtaining such equitable relief. 
 Assignment. You may not assign
your rights or obligations under this letter agreement without the Company’s prior written consent. You understand that the Company may assign this letter agreement without your consent to any entity (i) resulting from any merger,
consolidation or other reorganization involving the Company, including, without limitation, a merger or other reorganization for the purpose of changing the Company’s domicile, or (ii) to which the Company transfers all or substantially
all of its assets. 
 [Signatures on following page] 

  
 AVITA Medical 

28159 Avenue Stanford, Suite 220 Valencia, CA 91355 

P +1(661) 367-9170 | f +1 (661) 367-9180 | avitamedical.com 

 

 
  

 Please acknowledge your agreement to these terms by signing and dating a copy of this letter agreement where
indicated and returning it to the Company at our address listed below. 
  

			
	Sincerely,
	
	AVITA Medical, Inc.
		
	By:	 	 /s/ Dr. Michael S. Perry

	Name:	 	Dr. Michael S. Perry
	Title:	 	Chief Executive Officer
	
	Company Address:
	
	28159 Avenue Stanford, Suite 220
	Valencia, California 91355

  

			
		
	 AGREED AND ACKNOWLEDGED:
  

/s/ James M.
Corbett                                        
    
 (Signature)
  

James M. Corbett
 (Print
Name)
  
 Address:

17 Bravo Lane
 Aliso Viejo, CA 90656
	  	Date: May 28, 2021

  
 AVITA Medical 

28159 Avenue Stanford, Suite 220 Valencia, CA 91355 

P +1(661) 367-9170 | f +1 (661) 367-9180 | avitamedical.com

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00328-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00328-of-00352.parquet"}]]